UK-based prescribers
GPhC registered pharmacy
UK-based pharmacy
Weight loss specialists
Qualified clinical team
Confidential and discreet delivery
Dr Nivian Sukirthan is a UK-registered General Practitioner with the General Medical Council (GMC No. 7753776), holding qualifications including MBBS, MRCGP, iBSc, DRCOG, and DFSRH.
He has a strong clinical interest in preventative medicine and weight management, with experience supporting patients across a range of healthcare settings.
Dr Sukirthan is committed to helping patients achieve sustainable health and fitness goals through a medically guided, evidence-based approach.
His focus is on understanding each patient’s individual health profile, lifestyle, and long-term objectives to support safe, effective, and personalised weight management strategies.
Wegovy is a prescription-only weight loss treatment. It contains the active ingredient semaglutide, which mimics a natural hormone in your body. It helps control appetite and increases feelings of fullness, making it easier to reduce food intake and lose weight.
When combined with a healthy diet and regular exercise, Wegovy can support weight loss. It also offers additional advantages. These include improved cardiovascular health and a reduced risk of heart attack and stroke in adults with heart disease.
Note: To be eligible for Wegovy, you need to have a body mass index (BMI) of 30 or more, or 27 or above with a weight-related condition, such as high blood pressure.
Each weight loss pen of Wegovy contains 4 x weekly doses.Answer some questions about your health, review treatments, provide delivery address, and make payment online.
Our UK-licensed prescriber reviews your consultation within 24 hours to check treatment suitability, approves treatment or recommends the most suitable option for your health and needs.
If approved, your prescription weight loss medication is dispensed from a UK-based GPhC-registered pharmacy and delivered safely to you.
NOTE: Complete a 5-minute online medical assessment. A UK-licensed prescriber will review your information and decide whether treatment is appropriate; prescribing is not guaranteed. Wegovy Prices are indicative. If approved, Wegovy is dispensed by a GPhC-regulated pharmacy and supplied only after a successful consultation.
Wegovy is a licensed weight loss injection in the UK, specifically prescribed for weight management. It contains GLP-1, a natural hormone that helps regulate appetite and reduce food cravings. This medication has several key roles, including
Wegovy (semaglutide) is a prescription medication that mimics the natural hormone GLP-1 in the body, which is released after eating to help regulate blood sugar and signal to the brain that you're full. By copying this hormone, Wegovy reduces appetite, helping you feel full with fewer calories. Additionally, Wegovy injection slows the emptying of your stomach, prolonging feelings of fullness and reducing the urge to eat.
For optimal results, Wegovy should be used together with a reduced‑calorie diet and increased physical activity. In clinical studies, most adults taking weight loss pen alongside diet and exercise achieved clinically meaningful weight loss of at least 5% of their starting body weight.
Wegovy Injection may be prescribed after an eligibility assessment, which can be completed through our free online consultation form. This treatment is typically prescribed for adults who meet at least one of the following criteria:
A Body Mass Index (BMI) of 30 or above, or
A BMI of 27 or above with at least one weight-related health condition, including:
Eligibility will be confirmed after completing a medical consultation and review by a UK-licensed prescriber. Always read the patient information leaflet before commencing treatment.
Wegovy starts working from your first injection by helping regulate appetite and increasing feelings of fullness. Some people notice changes in hunger levels within the first few days, while noticeable weight loss usually develops gradually as the dose increases according to the recommended treatment schedule.
The amount of weight lost and how quickly results appear can vary between individuals. Factors such as your starting weight, diet, physical activity levels, dose progression and overall health can influence your results. Our clinician will monitor your progress throughout treatment to ensure Wegovy remains suitable for your individual weight management goals.
| Dose Frequency | Once weekly injection |
|---|---|
| Active Pharmaceutical Ingredient | Semaglutide |
| Drug Family | GLP-1 receptor agonist |
| How Wegovy works | Wegovy helps reduce appetite by mimicking the GLP-1 hormone released after eating and slowing digestion, helping you feel fuller for longer and support weight loss. |
| Maximum Weight Loss | Up to 15% after 15 months* |
| Available Strengths | 0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg, 7.2mg* Wegovy 7.2mg pack contains 4 individual pens, providing one injection per week for 4 weeks. |
Wegovy (semaglutide) can be taken by adults who:
In many cases, Wegovy (semaglutide) may not be suitable. Those instances include:
Wegovy supports weight loss, with results reported in clinical trials. In the latest studies, patients using the 7.2 mg maintenance dose lost an average of 20.7% of their body weight over 72 weeks, compared with 17.5% for those using the 2.4 mg dose and 2.4% in the placebo group.
Wegovy works best when combined with a healthy lifestyle, including a reduced-calorie diet and regular physical activity.
Beyond Weight Loss, Wegovy May Also Help:
Weight-loss results can vary depending on the Wegovy dose prescribed, treatment duration, and individual response. Clinical studies have shown that higher maintenance doses may lead to greater average weight loss in suitable patients.
Wegovy 7.2mg is supplied as four individual single-use pens. As this is a once-weekly treatment, one pen should be used each week, providing a complete four-week supply.
Weight-loss results can vary depending on the Wegovy dose prescribed, treatment duration, and individual response. Clinical studies have shown that higher maintenance doses may lead to greater average weight loss in suitable patients.
Wegovy is prescribed in a stepwise dosing plan, starting with the lowest dose to help your body adjust. The dosing schedule includes 5 different doses, gradually increasing over time to ensure safe and effective weight loss while minimizing potential side effects. Below, you’ll find the recommended Wegovy pen dosing schedule, along with an overview of Wegovy prices in the UK, which vary depending on dosages.
The starting dose of Wegovy is 0.25 mg. It costs £169.00 per month (4 weeks). This dose helps your body to adjust to the new weight loss medication.
The first continuation dose of Wegovy is 0.5 mg. It costs £189.00 per month (4 weeks). It is taken from week 5 to week 8 of starting the weight loss shot.
The second continuation dose of Wegovy is 1.0 mg. It costs £189.00 per month (4 weeks). It is preferably taken from week 9 to week 12 of your weight loss journey.
The third continuation dose of Wegovy is 1.7 mg. It costs £259.00 per month (4 weeks). It is prescribed from week 13 to week 16 of your weight loss journey when the body has adjusted to the weight loss shot.
Wegovy 2.4 mg is the standard maintenance dose and costs £309.00 per month (4 weeks). It is usually prescribed from week 17 onwards, once your body has adjusted through the earlier dose stages. Your prescriber may continue this dose or review whether a higher maintenance dose is suitable.
The 7.2 mg dose of Wegovy is the highest available maintenance dose and costs £339.00 per month (4 weeks). Is prescribed from week 21 onwards. By this stage, your body should be fully adjusted to treatment. You will usually continue this dose for the remaining duration of your weight loss programme. Wegovy 7.2mg pack contains 4 individual pens, providing one injection per week for 4 weeks.
Wegovy is a once-weekly subcutaneous injection, meaning it is injected into the fatty tissue beneath the skin rather than into a muscle or vein. You can administer your injection at any time of day, with or without food, but it is recommended to use it on the same day each week to maintain a consistent treatment routine.
Each Wegovy pen contains four weekly doses, providing one month's treatment at your prescribed strength. Before each injection, check that you are using the correct pen, inspect the solution to ensure it is clear and colourless, and always use a new needle.
Follow these steps to use your Wegovy injection pen safely:
Always use a new needle for every injection. Rotate your injection sites each week to help reduce skin irritation. Never share your Wegovy pen with anyone else, even if the needle has been changed.
If you are prescribed the Wegovy 7.2mg single-dose pen, the injection process differs from the multi-dose Wegovy pens. Before use, check that you have the correct strength, inspect the solution through the viewing window to ensure it is clear and colourless, and select an approved injection site.
Follow the instructions provided with your specific pen and patient information leaflet carefully. The 7.2mg pen is designed for single use and should be safely disposed of after completing your injection.
Watch this step-by-step video on how to use the Wegovy injection for weight loss. The video shows complete instructions for using the Wegovy (semaglutide) injection.
Wegovy UK is typically administered as a subcutaneous injection, meaning it’s injected just under the skin. The most common areas for this injection are the stomach, upper legs, and upper arms. To minimise discomfort, it's essential to rotate the injection sites each week. This practice helps prevent soreness or irritation at the injection site, ensuring a smoother experience with each dose.
Wegovy treatment can support weight management alongside appropriate dietary changes and physical activity. Potential benefits include:
If you forget to take your Wegovy injection and it has been 5 days or less since your scheduled dose, take it as soon as you remember. Continue with your next dose on your usual injection day, even if this means there are only a few days between injections.
If it has been more than 5 days since your missed dose, skip it and take your next injection on your usual scheduled day. Never take an extra or double dose to make up for a missed injection, as this may increase your risk of side effects.
Missing Wegovy doses frequently can reduce the effectiveness of your treatment. If you have missed two or more doses or have been without treatment for more than 2 weeks, contact our clinician for advice. They may recommend restarting Wegovy at a lower dose, particularly if you experienced stomach-related side effects before your treatment break.
Before starting Wegovy, it’s essential to inform our clinician about any other medications, supplements, or over-the-counter products you're currently taking. This will help our clinician to assess any potential interactions and make necessary adjustments to ensure your treatment is both safe and effective.
For individuals using insulin or sulfonylureas to manage type 2 diabetes, combining these with Wegovy injection may increase the risk of low blood sugar (hypoglycemia). As a result, our clinician may recommend more frequent blood sugar monitoring and adjustments to your diabetes medications.
It’s also crucial to avoid using weight loss medication alongside other GLP-1 receptor agonists, such as Mounjaro or liraglutide. Combining these medications can be dangerous, as it essentially doubles the dose, heightening the risk of severe side effects.
Wegovy weight loss injections may not be suitable for everyone. Treatment should be avoided during pregnancy, while trying to conceive or during breastfeeding, as the effects of semaglutide in these situations are not fully established. Wegovy is prescribed only for adults who meet the required eligibility criteria, including the relevant BMI requirements.
You should not use Wegovy weight loss injection if you have had a serious allergic reaction to semaglutide or any other ingredient in the medicine. It should also not be combined with other GLP-1 medicines, including treatments such as Saxenda or Mounjaro.
Before starting Wegovy for weight loss, share details of your medical history, current prescriptions, over-the-counter medicines and supplements with our healthcare provider. This helps your clinician determine whether Wegovy is suitable and identify any factors that may require additional monitoring.
Like all prescription medicines, Wegovy (semaglutide) can cause side effects, although not everyone experiences them. Most Wegovy side effects are mild to moderate and are more common when starting treatment or increasing your dose. These effects usually improve as your body adjusts to the medication.
These side effects often improve over time as your body gets used to Wegovy. They may temporarily return after a dose increase.
Although uncommon, some side effects require urgent medical attention. These may include:
For a complete list of possible side effects, always refer to the patient information leaflet provided with your medication.
Wegovy side effects can last from a few days to several weeks, depending on how your body responds to treatment. They are more likely to occur when starting Wegovy or after increasing your dose and usually improve as your body adjusts. Contact our clinician if symptoms continue, become worse or affect your daily activities.
Most Wegovy side effects are mild and often improve as your body adapts to the treatment. Simple steps, such as drinking enough fluids, choosing smaller meals and avoiding foods that are spicy, rich or difficult to digest, may help reduce common symptoms like nausea. For more information, read our Wegovy side effects guide.
If you experience side effects that continue, worsen or affect your daily routine, speak with our healthcare provider for advice. Seek urgent medical support if you develop serious symptoms, including severe abdominal pain, breathing difficulties or signs of a serious allergic reaction.
Back pain is not considered a typical direct side effect of Wegovy treatment. However, some people may experience back discomfort indirectly due to changes that occur during weight loss, digestive symptoms or other individual health factors. In some cases, back pain may also indicate another medical concern that requires assessment. Read more about back pain with Wegovy in our detailed guide.
If you develop persistent, severe or unusual back pain while using Wegovy for weight loss, speak with our healthcare provider. They can review your symptoms, identify possible causes and advise whether further checks or treatment adjustments are needed.
Wegovy itself does not usually dehydrate you, but digestive side effects such as vomiting and diarrhoea can cause your body to lose fluids. This risk may be greater when beginning Wegovy treatment or moving to a higher dose.
Drink fluids regularly, particularly when experiencing digestive symptoms. Our guide to staying hydrated on Wegovy provides further practical advice. Contact our healthcare professional if vomiting or diarrhoea continues, or if you develop signs of dehydration such as dizziness, reduced urination or difficulty keeping fluids down.
Yes, diarrhoea can be a possible side effect of Wegovy treatment. It is one of the more common digestive symptoms reported with semaglutide and may affect some people, particularly when starting treatment or after a dose increase. Wegovy changes how your digestive system works, which can lead to changes in bowel habits. Learn more about Wegovy and diarrhoea in our detailed guide.
These symptoms often improve as your body adjusts to the medication. Drinking enough fluids, eating smaller meals and avoiding foods that may trigger digestive discomfort can help. If diarrhoea is severe, continues for a long time or causes signs of dehydration, speak with our healthcare provider for advice.
Before starting Wegovy medication, your medical history and current medicines should be reviewed to make sure treatment is appropriate. Tell our healthcare provider about any existing conditions before using Wegovy injections, particularly if any of the following apply:
Wegovy injection should not be used if you are pregnant. If you are planning a pregnancy, semaglutide should be stopped at least two months before trying to conceive because it remains in the body for an extended period. Read our guide to Wegovy and pregnancy for further guidance. If you become pregnant while using Wegovy medication, stop treatment and contact our healthcare professional for advice.
You should not use Wegovy medication while breastfeeding because a risk to the breastfed baby cannot be excluded. Read our guide to breastfeeding and Wegovy for more information. If you are breastfeeding and considering weight management treatment, speak with our healthcare professional about suitable options before starting a Wegovy prescription.
Effective contraception is recommended while using Wegovy for weight loss to avoid pregnancy during treatment. Semaglutide itself is not expected to reduce the effectiveness of oral contraceptives. However, vomiting or severe diarrhoea can affect how contraceptive pills are absorbed, so follow the missed-pill guidance for your contraceptive and seek professional advice if necessary.
Wegovy is unlikely to impair your ability to drive or operate machinery. However, dizziness can occur, particularly while your dose is being increased. Do not drive or use machinery if you feel dizzy until the symptoms have resolved. People taking insulin or sulfonylureas should also be aware that low blood sugar can affect concentration and driving ability.
Wegovy weight loss injections may be used alongside insulin in some people with type 2 diabetes, but this requires clinical supervision. Wegovy does not replace insulin. Combining the treatments can increase the likelihood of hypoglycaemia, so our clinician may consider adjusting your insulin dose and recommend closer blood glucose monitoring.
No. Wegovy for weight loss should not be used at the same time as another GLP-1 receptor agonist, including another medicine containing semaglutide. Combining these treatments is not recommended and may increase the likelihood of adverse effects.
Before using this prescription weight loss injection, there are several important steps to consider:
Wegovy is approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, and is not only a treatment for obesity but also a powerful tool in improving heart health.
Clinical trials have demonstrated that using Wegovy for weight loss can lower the risk of major cardiovascular events, including heart attacks and strokes, by up to 20%. This makes it a significant treatment option for individuals struggling with obesity and related heart health concerns.
Wegovy may be suitable for some adults with type 2 diabetes, subject to a clinical assessment. If you use insulin or other diabetes medicines, your treatment may require closer monitoring because changes in blood glucose can increase the risk of hypoglycaemia. Our healthcare professionals will review your current medication and overall health before determining whether Wegovy treatment is appropriate.
Yes. You do not need to have diabetes to be prescribed Wegovy in the UK. It is licensed for weight management in eligible adults, generally including those with a BMI of 30 or above, or 27 or above with a weight-related health condition. Following a clinical assessment, suitable patients may be prescribed Wegovy as a prescription weight loss injection containing semaglutide.
The most appropriate Wegovy dosage is not necessarily the highest strength. Your dose should support weight management while remaining manageable in terms of side effects. Depending on your response to Wegovy treatment, a healthcare professional may recommend remaining at a lower dose rather than increasing it unnecessarily.
Wegovy dosage is generally increased gradually at 4-week intervals to help your body adjust. If you experience troublesome side effects, our prescriber may keep you at your current strength for longer. See our Wegovy dosing schedule for further guidance. Never change your prescribed dose without advice from a UK-licensed healthcare professional.
Using more Wegovy than prescribed can increase the likelihood of side effects, particularly nausea and other digestive symptoms. If you accidentally take an excessive or double dose of Wegovy, contact a healthcare professional promptly for advice. Do not take another dose or alter your dosing schedule until you have received appropriate medical guidance.
Some people notice less hunger within the first few days or weeks of starting Wegovy for weight loss. Appetite suppression may become more noticeable as the dose is gradually increased during the Wegovy treatment schedule. Individual responses vary, so you may not experience the same changes at the same stage as someone else.
Feeling hungry while using Wegovy for weight loss can be completely normal, especially during the early stages of treatment or before reaching your maintenance dose. Wegovy works by helping regulate appetite and slowing digestion, which can increase feelings of fullness, but it does not remove natural hunger signals completely. You can learn more about hunger on Wegovy and common reasons behind it in our detailed guide.
Everyone responds differently to Wegovy treatment, and factors such as your dose, eating habits, activity levels, sleep and stress can affect appetite. If you still experience hunger, focus on balanced meals with protein and fibre, maintain hydration and follow your prescribed plan. Speak with our clinician if you feel your appetite is not improving over time.
Signs that Wegovy treatment is having an effect may include feeling less hungry, experiencing fewer cravings, becoming satisfied with smaller portions and gradually losing weight. These changes are not the same for everyone and may become more noticeable as your dose is increased according to your prescribed treatment schedule
Weight loss with Wegovy for weight loss usually happens gradually rather than overnight. Our healthcare provider will review your progress by looking at changes in weight, appetite control and your overall response to treatment, helping determine whether your current plan remains suitable.
If your weight is falling faster than expected while using Wegovy for weight loss, make sure you are still eating enough nutritious food and drinking sufficient fluids. Smaller meals eaten regularly may be easier to manage if your appetite is significantly reduced. Always follow your prescribed dose schedule rather than moving to a higher strength early.
Healthcare professional if the pace of weight loss concerns you. Prompt medical advice is particularly important if you also develop ongoing vomiting, dizziness, dehydration or severe abdominal pain.
When using Wegovy for weight loss, aim for nutritious, balanced meals that include protein sources, wholegrain carbohydrates, fruit and vegetables. Smaller portions may be easier to manage when starting Wegovy treatment, especially if you experience nausea. Reducing high-fat and high-sugar foods may also help with digestive symptoms.
There is no universal calorie allowance for everyone taking Wegovy. Your ideal intake depends on factors such as your age, body composition, activity levels and health goals. A sustainable calorie deficit, based on professional guidance, can support gradual weight loss.
Everyone responds differently to Wegovy treatment, and noticeable weight changes may take time. Your results can be influenced by your prescribed dose, eating habits, activity levels, health background and how your body responds to semaglutide.
To support your progress with Wegovy for weight loss:
If you are not seeing expected changes despite following your Wegovy injection schedule, speak with our clinician. They can review your treatment plan, dose and other factors that may affect your progress.
The Wegovy 7.2mg dose is a higher maintenance strength available for eligible adults who have already reached and tolerated the 2.4mg maintenance dose. It may be considered for people who need additional support with weight management after reviewing their progress, treatment response and overall suitability.
The higher dose is not suitable for everyone and should only be started following clinical assessment. Our healthcare provider will consider factors such as weight loss progress, side effects and how well you have responded to previous doses before recommending any change.
Wegovy 7.2mg is still taken as a once-weekly injection, with dosing guided by your prescribed treatment plan. For more information, read our guide on the Wegovy 7.2mg dose, including eligibility, benefits, dosing and what to expect during treatment.
Clinical research shows that the higher Wegovy 7.2 mg dose can achieve greater average weight loss than the standard 2.4 mg dose. Over 72 weeks, adults with obesity taking semaglutide 7.2 mg lost around 20.7 % of their body weight, while those using 2.4 mg lost around 15–18%.
Individual results with semaglutide weight loss treatment vary depending on factors such as starting weight, lifestyle, health conditions and treatment response. Our clinician will monitor your progress and recommend the most suitable dose.
Wegovy and Mounjaro are two of the most commonly prescribed weight loss injections in the UK. Although both support long-term weight management, they differ in their active ingredients, how they work and their dosing schedules. The table below highlights the key differences between the two treatments.
| Feature | Wegovy | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| How does it work | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| Available doses | 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, 7.2 mg | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
| Time to maintenance dose | Usually 16 weeks | Usually 20 weeks |
| Average weight loss* | Around 21% at the 7.2 mg maintenance dose over 72 weeks | Around 22.5% at the 15 mg maintenance dose over 72 weeks |
| Manufacturer | Novo Nordisk | Eli Lilly |
Note: Weight loss data is based on the official Summary of Product Characteristics (SmPC) for Wegovy and Mounjaro. Individual results vary and should be considered alongside a reduced-calorie diet and increased physical activity.
There is no single treatment that is suitable for everyone. While Mounjaro has shown greater average weight loss in some clinical studies, Wegovy remains an effective long-term weight management treatment for eligible adults. The most appropriate option depends on your medical history, treatment goals, existing health conditions and our clinician's assessment of which medication is best suited to your individual needs.
Wegovy and Saxenda are injectable weight management treatments, but they contain different GLP-1 medicines. Wegovy contains semaglutide and is injected once a week, whereas Saxenda contains liraglutide and is taken every day. Their dose escalation schedules also differ, so the choice of treatment should be based on individual suitability and clinical assessment.
No, Mounjaro 2.5 mg and Wegovy 0.25 mg are not equivalent doses and cannot be directly compared. Although both are injectable weight loss treatments, they contain different active ingredients and work in different ways. Mounjaro contains tirzepatide, while Wegovy contains semaglutide. Read more about Mounjaro and Wegovy doses in our detailed guide.
If you are considering switching between Mounjaro and Wegovy, our healthcare provider will assess your treatment history, current dose and individual needs before recommending an appropriate starting dose. Do not switch or adjust doses without medical guidance.
Wegovy and Ozempic both contain the active ingredient semaglutide, but they are prescribed for different medical purposes. Ozempic is primarily used to help manage blood sugar levels in adults with type 2 diabetes, while Wegovy is specifically licensed for weight management.
Although they contain the same ingredient, the two medicines have different dosing schedules, strengths and treatment goals. They should not be used interchangeably unless advised by a healthcare professional. For more information, read our guide on switching from Ozempic to Wegovy safely, including key differences, dosing considerations and what to expect during the transition.
If Wegovy for weight loss is not suitable, other prescription options may include Mounjaro, Wegovy Pill and Foundayo. Mounjaro contains tirzepatide and is taken as a weekly injection, while Wegovy Pill and Foundayo are daily oral treatments containing semaglutide and orforglipron.
Each option works differently and has its own dosing schedule. A healthcare professional can review your medical history, current medicines and weight management goals to identify a suitable treatment.
| Comparison | Wegovy Injection | Mounjaro | Wegovy Pill | Foundayo |
|---|---|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide | Semaglutide | Orforglipron |
| Treatment type | GLP-1 | GIP and GLP-1 | GLP-1 | GLP-1 |
| Administration | Weekly injection | Weekly injection | Daily tablet | Daily tablet |
| Starting dose | 0.25 mg | 2.5 mg | 1.5 mg | 0.8 mg |
| Weight loss reported in studies | Up to 20.7% average body weight reduction | Up to 22.5% average body weight reduction | Up to 16.6% average body weight reduction | Up to 12.4% average body weight reduction |
| Prescription required | Yes | Yes | Yes | Yes |
There is no single weight loss treatment that works best for everyone. The most suitable option depends on your BMI, medical history, current medicines and individual circumstances. If Wegovy treatment is not appropriate, a UK prescribing team can assess whether another available option may be suitable.
Yes, some people may be able to switch from Mounjaro to Wegovy treatment after a clinical review. As there is no direct dose-for-dose conversion between tirzepatide and semaglutide, your new Wegovy dosage will be decided based on your current Mounjaro dose, treatment response, side effects and overall health.
The table below provides an indicative guide for doses that may be considered when switching:
| Current Mounjaro dose | Indicative Wegovy dose |
|---|---|
| 2.5 mg | 0.25 mg |
| 5 mg | 0.5 mg |
| 7.5 mg | 0.5 mg |
| 10 mg | 1 mg |
| 12.5 mg | 1 mg |
| 15 mg | 1 mg |
These doses should not be viewed as equivalent strengths. Our prescriber may recommend a different starting dose depending on your individual circumstances. Any switch between treatments should only be made with medical supervision.
Switching from Wegovy injection to Wegovy Pill may be suitable for some people after a clinical assessment. Although both contain semaglutide, they are different formulations with separate dosing schedules, meaning the doses cannot be directly matched. Our prescriber will review your current Wegovy dose, treatment progress and any side effects before recommending a suitable tablet dose.
The table below shows an indicative guide for doses that may be considered when changing treatment:
| Current Wegovy injection dose | Indicative Wegovy Pill dose |
|---|---|
| 0.25 mg weekly | 1.5 mg daily |
| 0.5 mg weekly | 4 mg daily |
| 1 mg weekly | 9 mg daily |
| 1.7 mg weekly | 25 mg daily |
| 2.4 mg weekly | 25 mg daily |
| 7.2 mg weekly | 25 mg daily |
These doses are not direct equivalents and your starting Wegovy Pill dose may vary depending on your health, treatment history and individual response. Any switch between Wegovy formulations should only be made with guidance from a healthcare professional.
If Wegovy for weight loss is not suitable or you prefer a non-medication approach, lifestyle-based strategies can support weight management. A balanced diet with fibre-rich foods, lean protein, whole grains and enough fluids may help with fullness and appetite control.
Regular movement, including cardio and strength exercises, can support healthy weight management. Mindful eating, better sleep and managing stress can also play an important role. For some people with obesity, specialist services may discuss other options, including bariatric surgery, where clinically appropriate.
Yes. The Wegovy Pill is a daily oral form of semaglutide, while Wegovy injection is taken weekly. Although both contain the same active ingredient, they have different administration methods and dosing schedules. A healthcare professional can review your circumstances and advise whether the tablet or injection form is suitable for you.
If you want to buy Wegovy online in the UK, it is important to use a regulated healthcare provider. Wegovy is a prescription-only medicine and can only be supplied following a clinical assessment to ensure the treatment is safe and appropriate for your individual health needs.
At London Slimming Clinic, you can buy Wegovy in the UK after your consultation has been reviewed by a UK-licensed prescriber. If approved, your medication is delivered discreetly, with ongoing clinical support available throughout your treatment.
To request a Wegovy prescription online, complete our online clinical consultation with information about your health, current medicines and weight. Our licensed prescriber will assess whether treatment is appropriate for you. Eligible patients may receive Wegovy UK prescription approval, with the medication then supplied through our regulated pharmacy and delivered discreetly to their chosen address.
To buy Wegovy online in the UK, you must first complete a confidential online medical consultation, where your BMI, medical history and current medications are assessed. This allows our clinician to determine whether Wegovy is a suitable treatment for your weight management goals.
To buy semaglutide online in the UK, you must meet the prescribing criteria. Wegovy is generally prescribed for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with a weight-related medical condition, alongside a reduced-calorie diet and increased physical activity. If approved, your prescription is issued by a UK-licensed prescriber and your medication is delivered discreetly to your chosen address.
At London Slimming Clinic, we offer Wegovy (semaglutide) at competitive prices, tailored to your individual treatment plan. The cost of Wegovy in the UK can vary depending on the dosage prescribed. Typically, higher dosages cost more due to their increased strength and longer duration of use. At London Slimming Clinic Wegovy prices Uk include full medical assessments and ongoing support to ensure your treatment is both safe and effective.
For optimal results, Wegovy should be combined with a balanced diet and regular exercise.
NOTE: Before you buy Wegovy online at London Slimming Clinic, a full medical assessment is required to ensure it is the right treatment for you. Wegovy must only be used as prescribed by a licensed healthcare provider. Bulk buying of Wegovy or sharing of the medication can pose serious health risks, as the treatment may not be clinically suitable for others.
You only need to use Wegovy for as long as it takes to reach your target weight. Some people then choose to stay on it for a while to help keep the weight off, while others stop once they feel ready. How long you use Wegovy is a personal decision made with medical guidance. It is approved for long-term use and can be taken safely when prescribed and monitored by a healthcare professional.
After six months, a UK-licensed clinician will review your progress. They will check whether you have lost at least 5% of your starting weight. If you have, and the treatment is helping without causing serious side effects, you may continue using Wegovy for as long as it remains suitable for you.
Wegovy (semaglutide) is not an addictive medication, so stopping treatment does not cause withdrawal symptoms. However, once you stop taking Wegovy, its effects on appetite regulation gradually wear off, which may lead to increased hunger and potential weight regain.
Clinical studies show that some people may regain part of the weight lost after stopping treatment. In one study of semaglutide 2.4 mg (Wegovy), participants regained around two-thirds of their previous weight loss within one year after discontinuing treatment. Maintaining a balanced diet, staying physically active and continuing the healthy habits developed during treatment can help support long-term weight management after stopping Wegovy.
Wegovy is supplied as a pre-filled weight loss injection in the UK. Depending on your order, suitable injection needles can be included when required, so you have the equipment needed to administer your prescribed dose correctly.
You do not need to source needles elsewhere. If required, compatible needles and a sharps bin can be added when placing your order, allowing used needles to be disposed of safely.
Small air bubbles inside a Wegovy pen can be normal and are not usually a reason for concern. The pen is designed to deliver the correct dose when used as directed, and small bubbles typically do not affect the effectiveness of your Wegovy injection. For more details, read our guide on Wegovy pen bubbles.
Always follow the instructions provided with your pen and avoid trying to remove bubbles by opening or adjusting the device. If you notice unusual issues, such as the pen not working correctly, leaking or difficulty delivering the dose, speak with our healthcare provider for advice.
It is important to read the Patient Information Leaflet (PIL) before starting treatment. These can be found in the packaging or Wegovy Patient Information Leaflet.
You can request Wegovy through the London Slimming Clinic by completing an online clinical assessment. The process involves:
Every Wegovy prescription is subject to clinical assessment, so completing the consultation does not guarantee that treatment will be prescribed.
If you are looking to order Wegovy online for the first time, your health information must be assessed before treatment can be supplied. You will need to:
This process allows our clinical team to assess whether Wegovy is suitable for you before treatment is prescribed. A standard Wegovy contains four once-weekly doses, providing four weeks of treatment. The Wegovy price varies depending on the prescribed dose strength.
Needles and sharps bins can be added to your order during your assessment.
START FREE CONSULTATIONMany patients have previously relied on London Slimming Clinic for clinically reviewed, weight loss treatments. All of them consistently reported satisfaction with timely clinical support and safe delivery of their medications.
Fill Online Consultation Form
Clinical Review by UK-registered clinicians
Get it delivered to your doorstep